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INTERCONVERSION OF CORTISOL AND CORTISONE IN NORMAL CONNECTIVE TISSUE 
OF MICE AND IN MALIGNANT (SARCOMA 37) CELLS IN HAMSTERS 
INTRODUCTION 
The most important function of connective tissue appears to be the 
maintenance of the physiologic state. Fibroblasts constitute about 90 
percent of connective tissue cells, and thus the state or activity of 
the fibroblasts and all factors which modify this state must be con-
sidered in relation to connective tissue functions. 
The activity of fibroblasts is directly related to the maintenance 
of a suitable environment in the tissues for optimal cellular function; 
the physiologic state. Fibroblasts are the cells which produce or 
synthesize collagen fibers and are responsible for the turn-over of 
ground substance mucopolysaccharides. Ground substance itself, on the 
other hand, is the environment of these cells, and the state of the 
ground substance in turn modifies fibroblast activity. 
Cortisol (Compound F) and cortisone (Compound E) are instrumental in 
maintaining the physiologic state following stressors like injury and sub-
sequent inflammation. These hormones act directly on fibroblasts which are 
their major target cells in connective tissue. 
Study of malignant cells in comparison to that of normal cells in 
connective tissue may yield information concerning the change or series 
of changes of the connective tissue as a whole or of a part thereof that 
may lead to malignancy. 
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In order to arrive at a better understanding of malignant cells, 
and so look forward to ways in which they may be controlled, experiments 
to be described have yielded data concerning the interconversion of 
labeled cortisol and cortisone in both normal connective tissue of mice 
and in Sarcoma 37 cells of hamsters. 
This thesis, then, describes a study of malignant cells in comparison 
to that of normal cells in connective tissue with the hope of obtaining 
answers concerning the change or series of changes of the connective 
tissue as a whole or of a part that may lead to malignancy. 
HISTORY 
I. General History of Connective Tissue 
Connective tissue is a special tissue composed of cells separated 
from one another by acellular matrix. It is derived from mesenchyme 
and thus from mesoderm~ The elements of connective tissue are: 
(A) Ground substance, (B) cellular elements, and (C) fibrous elements. 
The functions a~e: (1) ~o support and surround the elements of other 
tissues, (2) to fill out the spaces between the organs and act as a 
packing material, (3) to playa role in the nutrition of the elements 
embedded in it, and (4) to playa role in inflammation (1,2,3,4). 
Such early histologists as Jordan (1834), Henle (1841), and 
Burggraeve (1843), considered fibers the most important constituents 
in adult animal connective tissue, but they also described a few bare 
nuclei to which they paid little attention. Virchow (1859) recognized 
that the greater part of the connective tissue was composed of inter-
cellular substance of varying chemical nature in which cells were 
embedded. He was the first to claim that these cells persisted in 
adult connective tissue, and also that the cells were quite similar 
in different types of connective tissue. 
V. Recklinghausen (1863) was the first to describe two types of 
cells in connective tissue, one amoeboid and the other not; and he 
raised the question of the relationship between the two. He also said 
that in inflammation the pus cells were probably derived from white 
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blood cells rather than from connective tissue cells as Virchow con-
tended. The studies of Ehrlich (1877-1879) showed that some of the 
connective tissue cells had a marked affinity for certain aniline dyes 
such as dahlia. These elements he called ''Mastzellen'' because he 
thought that they were a depot of reserve food material. Ehrlich also 
demonstrated that certain connective tissue cells contain granules 
which stained red with eosin. Thus, he distinguished three cell types 
in connective tissue; mast cells, eosinophils, and cells not stainable 
with either eosin or dahlia. 
Before 1890, it was not customary to separate the outstretched 
spindle or star-shaped cells of the connective tissue into more than 
one type which were called connective tissue cells or fibroblasts or 
fibrocytes. However, Ranvier (1890, 1900) described another group of 
outstretched connective tissue cells which he called clasmatocytes, 
since he thought that they had the property of breaking loose small 
parts of their substance. He believed that the mast cells of Ehrlich 
were a variety of clasmatocytes. However, according to Maximow (1906, 
1913) and Jolly (1923) clasmatocytes and mast cells could be distinctly 
separated in most animals. Therefore, at this time there was much con-
fusion about macrophages (clasmatocytes), as we know them today, and 
their relation to mast cells and other cellular elements. Metchnikoff 
(1884, 1892, 1901), in a long series of investigations, called attention 
to the marked phagocytic properties of some of the connective tissue 
cells and called them macrophages. He ascribed to them an important 
role in the '~efense'r reactions of the organism. His cytological 
and morphological work was inadequate however. 
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Thus by 1900 it was known that the connective tissue was com-
posed of intercellular substance containing several cell types 
including mast cells, eosinophils, and fibroblasts or fibrocytes; 
and there was some confusion over clasmatocytes or macrophages. 
Maximow (1902, 1903, 1904, 1905, 1906) not only studied the 
detailed cytology of different types of connective tissue cells but 
also the parts each played in inflammatory reactions. With supravital 
neutral red staining, he was able to distinguish between fibroblasts, 
macrophages (which he called resting wandering cells), ameboid wander-
ing cells, connective tissue mast cells, eosinophils, plasma cells, 
and fat cells. Following connective tissue studies, Renaut (1904, 
1907) called macrophages "Cellules rhagiocrines" and gave a secretory 
function to them. 
The greater use of dyes, as acid aniline dyes and lithium carmine, 
led to a great extension of knowledge about the phagocytes of connect-
ive tissue (5). Histology texts as Bailey, Maximow and Bloom, and Ham 
give a clear picture of the development of connective tissue from 
stellate mesenchymal cells to macrophages, mast cells, fibroblasts, 
and endothelial cells. In 1940 Stearn (6) demonstrated that in the 
transparent rabbit ear chamber, fibroblasts are essential for the 
production of collagen fibers. Gersh and Catchpole (1949), R. E. 
Mancine (1950), Dougherty (1956), and Riley (196l) believe that the 
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ground substance in the adult is secreted by fibroblasts, while Asboe-
Hansen (1951) says it is secreted by mast cells. Work by Dougherty 
and Higginbotham (7,8,9) from 1955 to 1957 has confirmed that shed 
mast cell granules are phagocytized by fibroblasts, and in 1958, 
Dougherty and Schneebeli (33) made pictures of this process. Follow-
ing the work of Dougherty and Higginbotham, Riley (10,11) in 1961 and 
1963 hypothesized that fibroblasts produce mucopolysaccharides which 
are secreted to the tissue spaces where they are broken down and later 
picked up by mast cells. These mast cells store the mucopolysaccharides 
until trauma and the ensuing local inflammatory response cause their 
release. Fibroblasts then complete the cycle by ingesting and digest-
ing these mucopolysaccharides to satisfy their own metabolic needs. 
II. Amorphous Ground Substance of Connective Tissue 
The ground substance has been described as the amorphous continuum 
separating cells, vessels, and fibers of connective tissues. It con-
sists of mucopolysaccharides, proteins, salts, and water (12,13). 
A. Mucopolysaccharides 
The mucopolysaccharides have received a great deal of attention. 
They generally contain a small but significant proportion of associated 
protein material with the complex polysaccharide part of the structure. 
Acid mucopolysaccharides are macromolecular polymers of hexoseamine and 
hexuronic acid. Their ionic properties arise from their uronic acid 
components and varying amounts of esterification with sulfuric acid 
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(Higginbotham, 14). They are also flexible chain polymers of high 
negative charge with a strong affinity for cations and water mole-
cules. The following acid mucopolysaccharides have been isolated 
in connective tissue: Hyaluronic acid, chondroitin sulfate A, 
chondroitin sulfate B, chondroitin sulfate D, chondroitin, and 
keratosulfate (Meyer, 15). These acidic mucopolysaccharides exist 
in the tissues as complexes with other naturally occurring sub-
stances. They give the ground substance its gelatinous character, 
capacity to bind water, and physiochemical properties important to 
normal connective tissue function (Asboe-Hansen, 16). Ground sub-
stance varies from a liquid to a gel depending upon the state of 
polymerization. 
B. Staining Characteristics 
Ground substance is demonstrated by oxidative methods and meta-
chromatic staining (Angevine, 17). The Hotchkiss or Periodic Acid 
Schiff (PAS) reaction probably indicates the presence of polysaccharides 
(Robb-Smith, 18). Under certain conditions, the ground substance 
stains metachromatically. (Metachromasia is the phenomenom by which 
certain tissue structures are stained by basic dyes as toluidine blue 
in a color different from the color of the dye solution.) Gersh's 
theory (19) of the structure of ground substance holds that ground 
substance, if highly polymerized, stains weakly with Hotchkiss pro-
cedure, is palely stained with Evans blue, will show little or no 
metachromasia, and tends to be in a gel-form. Partially depolymerized 
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ground substance stains more strongly with Hotchkiss procedure, has 
a marked affinity for Evans blue and may be more metachromatic. 
Finally, highly depolymerized ground substance may stain more or 
less strongly with Hotchkiss procedure, will have a marked affinity 
for Evans blue, will probably be more metachromatic, and will in the 
end become water soluble. At this point, it may be broken down into 
particles small enough to enter the blood as mucoproteins (20,2l,19). 
Since changes in ground substance include increase or decrease of 
metachromatic staining, frequently accompanied by changes in the in-
tensity of staining by oxidative method, these changes may represent 
the degree of polymerization, changes in viscosity, or changes in 
the degree of sulfation (McManus, 23). 
c. Origin of Ground Substance 
There are two schools of thought as to the origin or source of 
the mucopolysaccharides found in ground substance. One school, which 
includes Gersh and Catchpole (19,20,21) believes that the fibroblasts 
produce and secrete the material which forms ground substance. They 
suggest that the fibroblast may control the state of polymerization of 
the ground substance and that the precursor of ground substance is a 
glycoprotein in the fibroblast together with a carbohydrate radical. 
They have also shown that granules and vacuoles in fibroblasts give 
the histochemical reactions of mucopolysaccharides, and that there 
are large amounts of mucopolysaccharides in certain types of fibro-
sarcoma. 
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The second school, led by Asbo~-Hansen (16) believes that the 
mast cell is the source of connective tissue mucopo1ysaccharides. 
Among other evidence, he points out that the mast cell stores, if 
not synthesizes heparin, a non-acety1ated sulfuric ester of glucur-
onic acid. 
It is not inconceivable that the ground substance mucopo1ysac-
charides come from both of these sources. 
III. The Fibroblast in Connective Tissue 
A. Description and Histology 
Fibroblasts are mu1tipotentia1 cells which are separated by 
ground substance and make up 90 percent of the cellular elements of 
loose connective tissue. They are called fibroblasts and not fibro-
cytes to denote their ability to form intercellular fibers and to 
change into other cell types when needed. According to most investi-
gators, these cells occur only in loose and dense connective tissues 
(3). 
In living loose connective tissue, the fibroblasts are sometimes 
difficult to observe as they are obscured by collagenous fibers (3). 
Their star-shaped bodies usually send out extensive cytoplasmic pro-
cesses which may branch and anastomose with those of other fibroblasts. 
These cell bodies may be demonstrated with iron hematoxylin. The 
nucleus is generally large, oval and stains lightly. It contains one 
or more round or angular pale staining nucleoli, and dust-like chromatin 
particles which are distributed quite uniformly throughout the nucleus. 
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The cytoplasm normally stains very lightly and is homogenous or finely 
granular. Numerous mitochondria, appearing as slender rods, are 
found closely packed, especially near the nucleus (Meves, 1910; 
Max imow , 1916, 1928)_ The cytoplasm also contains a diplosome and 
a Golgi net near the nucleus. Fibroblasts normally contain few in-
clusions except an occasional vacuole or fat droplet_ Inclusions are 
found in tissue culture, inflammation, or upon injection of foreign 
particles or macromolecules (3,4,S,24,2S). 
McManus (23) states that fibroblasts may contain inclusions of 
fat or protein and commonly contain carbohydrate. He also states 
that carbohydrates and lipids occur in the classical position of the 
Golgi element. Gersh and Catchpole (1949) have described the presence 
of PAS positive granules in the cytoplasm of fibroblasts and have re-
lated this to alterations in the PAS positivity of ground substance. 
With marked cellular hyperactivity, PAS positive granules are not 
present (23). Cytoplasmic basophilia is said to occur during in-
creased cellular activity (repair, tumor) and is related to metabolic 
activity. There also appears to be some relationship between the 
granulation and frequency of mast cells and the basophilia and activity 
of the fibroblast. 
The use of acid aniline dyes and lithium carmine in vital staining 
permits a ready means of separating fibroblasts from macrophages. 
Following i.v. or i.p. injection of these dyes, macrophages are found 
to store large amounts, while fibroblasts contain only a few granules. 
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Large amounts of trypan or isamine blue are also stored by fibroblasts, 
but generally in fewer and smaller granules. Fibroblasts have been 
shown to store these particles for a much longer period than do the 
macrophages. Even in extreme dye storage, the two cell types are 
distinguishable by their individual cytological characteristics; dif-
ferent nuclei, larger size of fibroblasts, etc. (Bloom, 5). 
Each fibroblast acts as an independent cellular element. In 
inflamed tissue and in tissue culture it moves with a gliding motion. 
Pseudopodia are usually not observed, but cells following in the 
direction of pinocytic filaments have been filmed (Schneebe1i, 26). 
In general, fibroblasts are not phagocytic for most things, but they 
do take up mucopo1ysaccharides, India Ink, and glucan, and may store 
some of them for extended periods. 
Fibroblasts are scattered singly or in groups among the collagen-
ous fibers in the loose connective tissue. Some workers as Dominici 
(1920), Heringa (1924), and W. and M. V. Mo11endorff (1926) believe 
the cytoplasm of adjacent fibroblasts to be continuous and form a 
syncytium; whereas W. Lewis (1922, 1926), Levi (1923), and Maximow 
(1916, 1927) believe that the processes are often in contact, but do 
not form a true syncytium. This latter opinion is generally accepted 
now (5). 
In late stages of scar formation, in inflammation, and tissue 
culture, and frequently about invading carcinomas, long thin fibrils 
have been described in the cytoplasm of the fibroblast. Maximow 
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first described them in 1902 in iron-hematoxylin stained preparations 
and called them tono-fibrils due to their r~semblance to similar 
fibrils in other cells. In 1904, Mallory demonstrated them also, 
calling them fibroglia fibers. They have sometimes been considered 
as precursors of the intercellular connective tissue fibers (5). 
B. Origin and Developmental Potencies of Fibroblasts 
Fibroblasts are direct descendents of the mesenchymal cells of 
the embryo, have a similar appearance to them, and it is difficult to 
tell at what particular stage a mesenchyme cell becomes a fibroblast. 
At any rate, fibroblasts gradually develop by individual metamorphosis 
of individual embryonal cells. 
There is still some difference of opinion as to whether the fibro-
blasts of loose connective tissue are undifferentiated elements or 
whether they are an end type cell. V. Mollendorff (1926), Weidenreich 
(1911), Benninghoff (1926), and others believed that the fibroblast of 
adult connective tissue is endowed with all the properties of mesen-
chymal cells, while Maximow (1902, 1927), Marchand (1924), and Aschoff 
(1924) agreed that fibroblasts of adult connective tissue are more highly 
differentiated cells. However, Maximow (1907) and Weidenreich (1930) 
felt that there was no doubt that in abnormal conditions fibroblasts 
could develop into osteoblasts and osteocytes (Bloom, 5). 
From tissue culture experiments much controversy arose as to 
whether adult fibroblasts could change to macrophages or macrophage-
like cells, and/or vice versa, thus proving developmental potencies. 
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From subcutaneous tissue cultures of the adult rabbit, Maximow (1916) 
concluded that fibroblasts are not converted into amoeboid cells in 
vitro, but that some macrophages can become fibroblasts in vitro. He 
believed that transitional forms between histiocytes and fibroblasts 
(seen in vitally stained animals) indicated development of fibro-
blasts from macrophages. M. von Mollendorff (1929), working also with 
rabbits, determined that fibroblasts of adult connective tissue can 
develop into macrophages, and showed in 1932 that fibroblasts would 
phagocytose or take up large quantities of carbon and R.B.C. On the 
other hand, Bloom (1931), who repeated these experiments, concluded 
that fibroblasts could turn into macrophage-like cells, but empha-
si~ed that the phagocytic nature of these cells had not been proved. 
There is now strong evidence that the rounding up of fibroblasts, 
resulting in resemblance to macrophage-like cells, is a property of 
the fibroblast in response to stress or application of hormones such 
as cortisol or cortisone (Dougherty, et aI, 27,28,29). There is also 
evidence that some of the lymphocytes which enter the connective tissue 
from the blood during inflammation may turn into macrophages. As the 
inflammatory process dies down, these macrophages may settle down as 
resting macrophages and some may later become fibroblasts (Bloom and 
Fawcett, 3). 
Another old idea of Virchow (1859) was revived by V. Mollendorff 
(1926) to the effect that in inflamed tissues exudate cells develop 
from fibroblasts after passing through a histiocyte stage. Maximow 
(1927, 1929) and Bloom (1928, 1931) felt that PMN's, lymphocytes and 
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monocytes came from the blood stream and that fibroblasts could be but 
an exceedingly insignificant source of polyblasts even in inflamed 
tissu6s. This is because of their small numbers as compared with 
lymphocytes. Maximow (1902) believed that lymphocytes may develop 
into fibroblasts (Bloom, 5). There is little doubt of this now. 
After these early controversies, the ability of the common fibro-
blast of the connective tissue to develop into macrophages and other 
types of blood cells was neither completely proved nor disproved, but 
it was considered definite that certain cells in adult connective 
tissue do have mesenchymal properties. Original mesenchymal potencies 
are retained by cells (undifferentiated mesenchymal cells or peri-
vascular cells) scattered in the loose connective tissue along the 
blood vessels. They are believed to be fibroblasts, endothelial 
cells, or fixed macrophages (Bloom and Fawcett, 3). These cells 
were demonstrated to turn into free macrophages, lymphocytes and 
myelocytes (Marchand, 1924; Maximow, 1926); and into osteoblasts 
and fat cells (Herzog, 1928, and Bloom, 5). 
At present, the majority opinion holds that fibroblasts are 
differentiated cells which generally do not give rise to other types 
of free cells in the loose connective tissue (Bloom and Fawcett, 3). 
Some investigators believe that, under the influence of external 
stimuli, all fibroblasts can produce any cell type of the blood and 
connective tissue (Bloom and Fawcett, 3). There is, however, an 
increasing opinion that the fibroblast is a multipotential cell, 
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which under certain conditions may become an endothelial cell, a fat 
cell, a chondroblast, an osteoblast, etc.; but that it probably does 
not give rise to macrophages and only rarely forms myeloid elements 
(Bloom, 5; Dougherty, 24). 
There is also much feeling that fibroblasts, lymphocytes, and 
RE cells are closely related functionally, and there is evidence 
that they may be morphologically and functionally interchangeable 
under certain circumstances (Dougherty, 24). 
c. Functions of Fibroblasts 
With changes in function, the morphology of fibroblasts may 
change. Some fibroblasts in a population may be specialized for 
the formation of collagen, others for polysaccharide, some for de-
position of fat, etc. Steroid hormones may also influence the 
functions of these look-alike cells. 
1. Synthesis of Materials and Structures: Fibroblasts per-
form most of the functions attributed to the supporting framework of 
the body. They construct much of their framework and produce the 
matrix in which they find themselves (Dougherty, et aI, 27; Berliner 
and Dougherty, 30). Fibroblasts are essential for the production of 
collagen fibers, may produce elastic fibers, and may synthesize or 
produce ground substance mucopolysaccharides and participate in the 
metabolism of these tissue mucopolysaccharides (Dougherty and Berliner, 
28). Fibroblasts also synthesize as well catabolize mucoproteins 
(Higginbotham, 14). Also, they are major producers of cholesterol 
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and may secrete this substance (Dougherty and Berliner, 29,31). 
2. Localization of Cortisol: That the fibroblast is the main 
cellular site for the localization of cortisol was shown by Dougherty 
and Schneebeli (27). They determined the cellular localization of 
cortisol in connective tissue by giving C14 labeled cortisol sub-
cutaneously to adrenalectomized mice. It was found that the fibro-
blasts contained the hormone for a time either in the cytoplasm or 
at the cell surface. At any rate, cortisol produced definite changes 
in the appearance and function of fibroblasts during the time it acted 
on these cells. Macrophages and lymphocytes did not appear to con-
centrate cortisol or retain it for any long period, and they could 
not perform the transformations that fibroblasts do. Fat cells also 
contained little cortisol. Thus, the greatest amount of radioactive 
hormone was concentrated by fibroblasts. 
D. The Action of Cortisol on Fibroblasts 
All actions of cortisol on fibroblasts are direct effects and 
do not appear to be mediated through systemic mechanisms. The fact 
that one event may be affected by a different dosage than another 
event is important in the cause and treatment of connective tissue 
disease (Dougherty, et aI, 28). 
1. Interference with Fibroblastic Functions; The proliferation 
of fibroblasts or their multiplication may be inhibited by cortisol 
(Dougherty, et aI, 28,29). Collagen deposition likewise may be re~ 
duced by cortisol. Since cortisol tends to inhibit wound healing 
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and growth of fibroblasts in tissue culture (Dougherty and Schneebeli, 
32), it may act by interrupting mitosis. Cortisol may also decrease 
the synthesis of ground substance, since it has been shown that 
synthesis and/or deposition of polysaccharides is inhibited by corti-
sol (Dougherty, et aI, 28,29,33). 
28 Inflammation: The most important physiological action of 
cortisol on the fibroblast occurs during inflammation (Dougherty, 
34,35)8 Inflammation, actually, is just a pathological expression 
of normal physiological processes. 
At an early stage of the inflammatory response, cortisol inter-
rupts and inhibits the chain reaction of fibroblastic destruction by 
causing the fibroblasts to pull in their processes, round up, and 
become epithelioid in app~arance (Dougherty, 29,35,36). Cortisol 
exerts this antiphlogistic effect by inhibiting the focal damage to 
fibroblasts and by preventing the influx of PMN's, lymphocytes, and 
macrophages into the injured area (Ragan, 37). The rounded fibro-
blasts may persist in spite of enormous fibroblastic damage. The 
severity of the infla~mation and the amount of cortisol present 
determines the amount of fibroblast destruction. However, the less 
the metabolism of cortisol the greater its anti-inflammatory effect, 
and vice versa (31,35). 
It has been found in our laboratory (33,38) that the length of 
time that cortisol is present in the fibroblast is much shorter than 
the period in which inflammation is reduced. The maximum concentration 
18 
of radioactive cortisol in the connective tissue after administration 
was found to be about 40 minutes, whereas the anti-inflammatory effect 
lasts about three hours and sometimes more. It therefore appears that 
cortisol triggers some mechanism which continues after the hormone is 
catabolized and excreted (38). It has also been demonstrated that 
though there are no special mechanisms tending to localize cortisol 
in connective tissue in inflammation, more cortisol is found in the 
inflammatory area due to the edema which brings in many non-specific 
substances, including cortisol. 
The 17 OH structure on the steroid nucleus is absolutely neces-
sary for the anti-inflammatory effect and for the epitheliazation of 
fibroblasts, whereas the OR at position 11 is not necessary. The 
most effective compounds in this respect include cortisol, which is 
the most effective, cortisone, and Substance S. 
Conversion of cortisol to other compounds is inhibited in inflamed 
connective tissue. In other words, fibroblasts in the zone of inflam-
mation seem to have lost their ability to oxidize or reduce the 
positions of the cortisol molecule. However, it may be that in 
incubations of inflamed connective tissue, where there are fewer 
fibroblasts due to many having been destroyed, steroid compounds, if 
present, could not be detected by the methods used (28,29,32,33,38,36, 
35,39,40). 
Thus, inflammation once initiated could be greatly affected by a 
deficiency of the hormone supply or by alteration in fibroblast meta-
bolism. 
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3. Destruction of Fibroblasts: Large doses of cortisol destroy 
fibroblasts and RE cells. Smaller doses of cortisol cause destruction 
of some cells and change the remaining cells as discussed above. Pino-
cytosis is absent and the fibroblast appears anesthetized. The cytoplasm 
becomes densely basophilic and contains vacuoles which are filled with 
reducing substances as shown by the phenyl hydrazine, TPTZ, and tetra-
zolium blue reactions. Fibroblasts began to assume a spherical shape 
within 15 minutes after the tissues were exposed to cortisol. After 
45 minutes, the hydrazine reaction could be shown by the presence of 
positive granules in the fibroblasts. After one hour, NTZ granulation 
was noted demonstrating the presence of reducing groups. These sub-
stances persisted after radioactive cortisol could not be detected 
(27,28,29,31,33). 
IV. Effects of Hormones on Connective Tissue 
Hormones exert regulatory influence on connective tissue cells 
(16,37,41,42,43). Although primary attention is directed to the 
effects of cortisol on fibroblasts, other hormones also exert in-
fluences. These will be reviewed here. 
Hormones may accelerate or dep~ess the activity of normal pro-
cesses in connective tissue (Loeb, 37). They may interfere with 100 
or more enzyme systems (Asboe-Hansen, 16,41). The hormones active in 
connective tissue metabolism are many. A summary of hormonal actions 
on connective tissue is presented in Table I by Taubenhaus (22). 
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First, the pituitary hormones will be discussed, including growth 
hormone) thyrotropic hormone, and gonadotropin. These hormones may 
act through their target organs, or directly as may be noted below. 
Then the other hormones, including adrenal cortical hormones, thyroid 
hormones, parathyroid hormones, the sex hormones (estrogens and 
androgens), and progesterone will be discussed. The effects of 
cortisol have already been reviewed separately in greater detail. 
A. Growth Hormone 
Growth hormone accelerates and increases fibroplasia, stimulates 
mast cell production of acid mucopolysaccharides, stimulates the for-
mation of collagen from fibroblasts, and stimulates the proliferation 
of granulation tissue (Asboe-Hansen, 16; Ragan, 37). 
B. Thyrotropic Hormone 
This hormone has a direct effect upon the connective tissue. An 
injection of this hormone in guinea pigs is followed by a mobilization 
of fat from normal depots to liver, kidneys, cardiac, and skeletal 
muscle (Duran-Reyna Is , 43; Asboe~Hansen, 16,44). Tissue fat is re-
placed by a mucinous substance, mainly hyaluronic acid. The content 
of hyaluronic acid in connective tissue is increased in myxedemateous 
(hypothyroid) subjects, manifesting itself by an inhibition of spread-
ing in the skin, but increasing the spreading effect of hyaluronidase. 
Thyrotropic hormone may affect the function of mast cells, perhaps 
increasing their number and influencing them to secrete hyalurohidase-
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sensitive mucopo1ysaccharides as hyaluronic acid into the connective 
tissue (Ragan, 37; Asboe-Hansen and Iverson, 45). Since mucopo1ysac-
charides, as hyaluronic acid, possess a marked capacity to bind water, 
an increased content of these substances may explain exophthalmos. 
c. Gonadotropin 
Gonadotropin increases the spread of tubercle bacilli in the 
skin of rabbits, increases vascular p~rmeabi1ity, and increases the 
permeability of connective tissue ground substance as a whole (Asboe-
Hansen, 16). 
D. Adrenal Cortical Hormones 
Adrenal cortical hormones as cortisol and cortisone decrease 
fibroplasia and have anti-hyaluronidase action, i.e., they reduce the 
spreading capacity of hyaluronidase in rabbit and human skin. They 
also depress or inhibit depo1ymerization by hyaluronidase (16,41,44, 
46,47,48)~ These hormones, especially cortisol, are used in diseases 
of mesenchymal tissues, in hypersensitivity, in acute inflammation, 
and in some allergic diseases due to their anti-inflammatory activity 
(27,32,46,49,50). Desoxycorticosterone (DOCA) should be mentioned as 
its effects are opposite to those of cortisol and cortisone. It ac-
celerates and increases fibroplasia (37), increases depolymerization 
of mucopolysaccharides by hyaluronidase, and counteracts the inhibi-
tory effect of cortisone in wound healing (37). It also acts in the 
absence of the adrena1s (Seifter, 47). 
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E. Thyroid Hormone 
This hormone resolves myxedematous connective tissue changes, 
and causes the accumulation of mucinous substances, mainly hyaluronic 
acid, to subside (Asboe-Hansen, 16,41). However, it decreases the 
spreading effect of hyaluronidase since there is less hyaluronic acid 
to act on. Further, thyroid hormone inhibits pituitary production of 
thyrotropic hormone, increases the metabolic rate, causes the mast 
cells to become small and faintly granulated, and increases spreading 
in the skin. 
F. Parathyroid Hormone 
This hormone may increase the production of mucopolysaccharides 
and decrease the permeability of connective tissue (Asboe-Hansen, 16). 
Go Estrogens 
In loose connective tissue, estrogen is responsible for an in-
crease in the immature elements. It induces a rejuvenation process. 
In the dense connective tissue, it stimulates maturation (Muller, 51). 
However, Meir~ et al (52), have done in vitro experiments with estra-
diol in which disturbances in mitosis of fibroblasts were produced 
without essentially affecting the growth of fibroblasts. 
Estrogenic hormones inhibit spreading in rabbit skin (Asboe-
Hansen, 16). There is an increased resistance to the spread to 
tubercle bacilli, other infections, and India Ink. This may pos-
sibly be due to an increase in the mucopolysaccharide content of 
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the connective tissue, especially of hyaluronic acid. However, intra-
dermal injection of hyaluronidase, when estradiol is locally applied 
to rabbit skin, increases the rate of spread in rabbit skin (Baker 
and Abrams, 42). 
Old male fowls, caponized or treated with diethylstilbesterol 
showed a marked decrease in the tensile strength of the skin and 
muscles and a decrease in the amount of collagen in these tissues 
(Herrick and Brown, 53). 
Naturally, the effects of estrogen are considerably modified by 
the ovaries, pituitary, and adrenals (Muller, 51). 
The sex hormones could not be regarded as significant growth 
stimulating agents upon fibroblasts (Von Haam and Cappel, 54). It 
was shown, however, that estrin, at certain levels, did increase the 
mitotic index over controls and that the surface area of growth was 
increased. 
H. Androgens 
Testosterone propionate, given to capons, causes them to develop 
increased tensile strength and collagen levels in the skin, which de-
creases after this hormone is discontinued (Asboe-Hansen, 16; Herrick 
and Brown, 53). Applied locally in the normal animal, testosterone is 
said to inhibit the migration of WHC, and to inhibit the growth of 
fibroblasts to a slight extent (Meir, et aI, 52). With androgen admin-
istration there may also be an increase in polysaccharides as hyaluronic 
acid in the cock's comb; and it may be that androgens increase the 
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synthesis of hyaluronic acid (52). 
I. Progesterone 
The action of p~ogesterone appears to be somewhat opposite to 
that of estrone (Asboe-Hansen, 16). It appears to inhibit the migra-
tion of WBC and to inhibit the growth of fibroblasts to a greater 
extent than does testosterone (Meir, 52). 
J. Aging 
Aging should be mentioned in passing, since it certainly affects 
connective tissue considerably. With advancing age, the ratio of 
ground substance/collagen decreases and binding of water decreases. 
Thus, the formation of mucopolysaccharides in connective tissue is 
reduced, the mast cell count drops, the connective tissue macrophages 
are decreased, and elastic and collagen fibers change (Asboe-Hansen, 
16). 
v. Corticosteroids: The Adrenal Cortical Hormones 
A. The Chemistry of Adrenal Cortical Hormones 
Thirty crystalline compounds have now been obtained from extracts 
of adrenal glands. These steroids include estrone (C-IB compounds); 
some androgens (C-19 compounds); progesterone, cortisol, cortisone, 
etc. (C-21 compounds); and cholesterol (C-27 compounds). Of the 
adrenal steroids, seven have significant adrenal cortical activity 
(White, Handler and Smith, 55; Sayers, 56). See figure 1. 
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B. Relation of Structure to Physiological Activity 
The physiological activity of corticosteroids varies with vari-
ations in chemical structure. Hydroxylations at key positions change 
the biological activity of a steroid. For example, progesterone has 
high gestagenic and mild mineralocorticoid effects. Hydroxylation of 
progesterone at C-2l gives desoxycorticosterone, a compound with more 
sodium-retaining activity. Hydroxylation of progesterone at C-2l, and 
C-17 gives us cortisol which has gluconeogenic, anti-inflammatory, and 
lymphokaryorrhetic activities. Four structural features are of great 
importance in determining the biological activity of these compounds 
(Pincus, et aI, 57): (1) The alpha-B unsaturated 3-ketone grouping; 
(2) the side chain with a ketone at C-20; (3) an alcoholic or ketonic 
oxygen atom substituted at C-ll; and (4) the presence or absence of an 
OH at C-17. A C-ll OR regulates lymphatic tissue growth (58,59,60,61, 
62,63), whereas a C-17 OR is necessary for anti~inflammatory effect 
and for epithelialization of the fibroblast (Dougherty, et aI, 30). 
C. Metabolism of Adrenal Cortical Hormones - Cortisol 
i 
In studies of laboratory animals and in normal and diseased 
humans, it has been found that there is a considerable similarity in 
the ways in which adrenal cortical hormones are metabolized. Cortisol 
is synthesized by adrenal cortical cells and released to the blood. It 
is carried in the blood bound to a specific globulin called transcortin, 
which is produced in the liver. The amount of transcortin is increased 
by ACTH and estrogen (55). 
26 
The metabolism of cortisol (F) is very rapid. The steroid has 
a half life of about 47 minutes in the normal human, and nearly the 
same in rats and mice. As soon as the hormone arrives in the blood, 
it begins to leave. It passes from the capillaries into the connect-
ive tissue in a passive manner, similar to that of other blood con-
stituents. Following administration in the mouse, the maximum 
concentration of cortisol is found in the blood at 20 minutes, but 
the maximum concentration of hormone in the connective tissue is not 
reached until 40 minutes. Cortisol moves through the ground substance 
and tends to localize at the surface of the fibroblasts, or in them, 
causing them to round up and resemble epithelial cells. This process 
enables the cell to acquire resistance to the waves of cellular de-
struction occurring in inflammation by interrupting the chain reaction 
of cellular damage. This has been shown by histological, histochemical, 
and radioautographic studies in our laboratory (28,30,32,38,36). 
Through a series of oxidations and reductions, cortisol is rapidly 
transformed or converted by the fibroblasts to other steroid hormones 
which are in general either inactive (substances E and U of Reichstein) 
or potentially active as cortisone. See figure 2. These end with 
removal of the side chain (28,29,31,59,64). 
As the conversion products of cortisol are formed, they pass into 
the blood and to the liver. Here they are conjugated mainly with 
glucuronic acid and subsequently excreted by both the renal and biliary 
systems (28,30,36). Thus, cortisol can be changed chemically by the 
fibroblast in the connective tissue. 
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D. Biotransformation 
Biotransformation of steroids is metabolism occurring by a series 
of oxidations and reductions in non-endocrine tissues. This is peri-
pheral metabolism and it includes hepatic and extra-hepatic metabolism. 
It is transformation toward a compound having a different function than 
the original molecule (28,39). 
One of the most active cells of the extra-hepatic metabolism of 
steroids is the fibroblast. It has the ability to oxidize and reduce 
the various substituted groups on the gonane nucleus and can thus 
regulate the degree of activity or inactivity of the steroid molecule 
(Dougherty and Berliner, 30; Dougherty, et al, 28). For example, the 
fibroblast may transform cortisol to steroids completely lacking in 
anti-inflammatory activity (Dougherty and Berliner, 31). 
Metabolites isolated in our laboratory include cortisone, Reich-
stein's E and U, some dihydro F, and C-19 compounds as androstenedione. 
There is some corticosterone also (28, 31; Berliner and Dougherty, 64). 
Molecular changes include oxidation of the OR group in position C-ll, 
some reduction of the 4-5 double bond, reduction of the C-20 ketone 
(C-20 01 form) and oxidative cleavage of the side chain (Dougherty, 
28,36). 
When cortisol is metabolized to cortisone, it may in part still 
be reversibly transformed to cortisol and thus be biologically active; 
but if it is metabolized to compounds reduced at the C-20 or those in 
which the side chain has been removed, it is irreversibly transformed 
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to biologically inactive compounds. Cortisol also has a slight ability 
to reduce ring A to give dihydro F (Berliner and Dougherty, 39). Thus, 
the degree of reversibility regulates the amoune of biological activity. 
Also, in general, the greater the state of reduction of the steroid 
molecule, the less active it is biologically; and if biotransformation 
can be inhibited, biological activity can be enhanced (28,39). Co-
factors DPN, TPN, DPNH and TPNH are necessary for the transformations 
of cortisol by fibroblasts. 
TABLE I 
HORMONE SYNERGISM AND ANTAGONISM 
IN TISSUE REACTIONS 
Taubenhaus, M. (22) 
General Collagen 
Effect Fibro. Fibers 
Ant. Pit. 
Growth Stirn. Large, normal Thick 
Hormone contour 
Thyro:Kin Stirn. in Normal Normal 
deficient 
animals 
DOC Stirn. Large, poly- Dim. 
gonal or 
stellate 
Cortisone Inhib. Small Inhib. of 
longitude 
growth 
Estrogen Inhib. Small, flat Thin 
Testosterone Inhib. Small Thin 
Footnote: Taubenhaus, M. Hormone Synergism and Antagonism 
in Tissue Reactions. Reprint from Bulletin de 
l'Academe Suisse des Sciences Medicales Vol. 8 
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VI. The Sarcoma 37 Cell 
A sarcoma (fleshy tumor) is a malignant connective tissue neo-
plasm. Sarcoma 37 is a particular connective tissue tumor which has 
been transplanted consecutively over a long period of time. It is 
very malignant and may cause death in about 30 days when injected sub-
cutaneously in hamsters. !here are two forms of the tumor; the ascites 
form which is transplanted intraperitoneally, and the solid form which 
is transplanted subcutaneously or intramuscularly. This tumor is 
homo trans plantab Ie , though it shows a definite preference for some 
strains. Mice and hamsters appear to be the animals of choice. In 
rats it gives a percentage of takes, but the tumors usually regress 
(Pikovsli and Schlesinger, 65). 
A. Microscopic Picture and Characteristics of Sarcoma 37 
If ascites sarcoma cells are injected into peritoneal cavities of 
mice, most of the tumor cells may be harvested as a cell suspension in 
the peritoneal fluid. However, cells injected subcutaneously form a 
solid mass of adherent cells. The cells may change from the ascites 
form to the solid tumor form and vice versa, depending upon the site 
of injection. Cook, Seaman, and Weiss (66) compared seven day Sarcoma 
37 ascites and solid tumor cells and showed by cell electrophoresis 
that there was a significant difference in mobility between cells de-
rived from the ascites and solid forms of mouse Sarcoma 37. 
1. Cell Types: Studies were performed on the solid form of 
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mouse Sarcoma 37 grown in hanging drop tissue culture, and the cell 
types were examined (Hogue and Rubin, 67). After 24 hours, three cell 
types were observed~ (1) Spindle-shaped cells with blunt processes, 
(2) cells with irregular tortuous processes (looking like fern fronds) 
which apparently become spindle-cells after two or three days, and 
(3) small cells resembling mouse lymphocytes, which were amoeboid. 
Death from intracavitary inoculation occurred in most animals 
earlier than that following subcutaneous inoculation. Subcutaneous 
tumors of the flank invaded connective tissue and muscles by several 
encircling layers, which in their growth obliterated normal tissue and 
vessels with perivascular damage and hemorrhage. The tumors reached 
considerable weight, 2-4 grams. Survival times of mice depend upon 
the route of injection. These are summarized in Table II (Goldie, 
et aI, 68). Mortality of mice given inoculations by various routes 
and various topographical sites illustrates that there may be early 
death in spite of a small amount of tumor tissue or later death when 
the tumor is large and organized. 
Chu (69) studied intramuscular Sarcoma 37 transplanted subcutan-
eously into CAF mice. He note~ that before vascularization occurred 
at 3-4 days after inoculation, the cells were arranged in three zones: 
(1) Peripheral zone of giant cells, (2) an intermediate zone of spindle 
cells, and (3) a central zone of necrotic cells. After granulation 
tissue brought in more macrophages and giant cells and became incorpor-
ated into the implant, a new layer of granulation tissue formed around 
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the growing tumor, and this now well-vascularized tumor was observed 
to contain a mixture of spindle and necrotic cells. Chu noted that 
vascularization seemed to supply nutriment as well as cellular elements 
for growth of the daughter tumor. 
Other authors, including Sylven (70,71) have described three areas 
in Sarcoma 37 tumors: (1) An outer layer of cells (A cells) contain-
ing the growing and dividing cell types, (2) an area of B cells near 
the center which are non-growing tumor cells with different cytological 
and enzymatic characteristics, and (3) a central necrotic area, the 
size depending upon whether the tumor is young and well-vascularized 
with a small necrotic area, or not. 
2. Metabolism: Obviously, the composition of central fluids 
will be influenced by products released during cell injury and auto-
lysis. In the B cell compartment relatively high levels of glucose 
were found (Burgess and Sylven, 70). This may suggest a deficient 
utilization of glucose. Also, lactate concentration was lower here 
than in young fully vascularized tumors. 
Many studies have been done as to the characteristics of Sarcoma 
37 tumors. Most tumor tissues, including Sarcoma 37~ have a decreased 
content of glycogen together with a high rate of glycolysis (Nigram, 
et aI, 72). These same tissues also showed a lower activity of 
phosphoglucomutase and glycogen synthetase, as compared with normal 
liver and muscle. There were also decreased phosphorylase levels. 
Nigram and co-workers (72) suggest that these tumors may contain a 
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defective system for glycogen synthesis owing to low activities of the 
enzymes involved. 
Microscale assays of protein, glucose, lactate (LA) and total 
lactic dehydrogenase (LDH) activity in samples of free interstitial 
fluid from solid unicentric transplants in mice (intramuscular 
Sarcoma 37 tumor) were compared with those in plasma and intraperitoneal 
fluid from normal and tumor mice (70). The tumor fluids contained 
greater amounts of protein, LA, LDH, and glucose than normal inter-
stitial fluid - the highest values being in the central fluid of young 
tumors. The authors concluded that the composition of interstitial 
fluid of solid tumors is very different from that of normal inter-
stitial fluid. It was also pointed out that there are marked dif-
ferences between Sarcoma 37 solid and ascites tumors. For example, 
it is considered that there is a high rate of glucose metabolism in 
many solid tumors (including Sarcoma 37), and therefore, one might 
expect low glucose levels in these tumors. However, there are found 
to be large quantities of glucose in both the peripheral and central 
fluids of these tumors while ascites tumors contain low levels of 
glucose. Also, there appear to be lower enzymatic activities (argi-
nase, dipeptidase, glutathione reductase) in older tumor cell gener-
ations than in young ones and in ascites tumors than in solid ones 
(Malmgren and Sylven, 71,73). 
When soluble proteins from different types of malignant tissues 
in mice were chromatographed on DEAE (diethylaminoethyl cellulose), 
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Sarcoma 37 and all other tumors examined showed a similar protein and 
enzyme pattern (Pikovsli and Schlesinger, 65; Roberts, 74). The auth-
ors felt that the results indicated that tumor proteins resemble one 
another closely and that tumors, regardless of their tissue of origin, 
have similar enzymatic patterns, 
There was also a consistent pattern of distribution of free amino 
acids in malignant tissues which was different from that of any of the 
normal tissues studied (Angeletti, et aI, 75). 
Daoust and Amano (76) examined the ribonuclease and deoxyribo-
nuclease activity of 65 experimental and human tumors (including 
Sarcoma 37) by histochemical substrate film methods. The same gen-
eral pattern for the distribution of these nucleases was found. The 
connective tissue stroma and necrotic regions of the tumor masses 
showed various levels of nuclease activity, whereas the neoplastic 
cells showed none. It appears that deficiencies in the two nuclease 
activities represent general properties of cancer cells. The authors 
suggested that loss of nuclease activity by the cell might allow 
foreign nucleic acids (viral and other) to become part of the genetic 
material, alter the properties of the cells, and possibly induce 
neoplastic transformations. 
Tumor growth of Sarcoma 37 is accomplished by accelerated 
cellular multiplication and increased DNA (desoxyribonucleic acid) 
synthesis (Havas, et al~ 77). 
Fatty acids (octanoate, decanoate) inhibit the respiratory 
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activity of mitochondria in tumor slices of mouse Sarcoma 37 (Schole-
field 9 78). The long chain fatty acids are the more effective inhib-
itors, and the effects appear to be due to the fatty acids themselves. 
Glucose inhibits respiratory activity also. 
B. Effects of Bacterial Toxins on Sarcoma 37 
For more than 200 years, the observation has been made that human 
malignant growths may at times regress following an acute infection, 
usually streptococcal in nature. The active principle in these mix-
tures waS not then known. Now many experiments have been done using 
the "toxins" from different strains of microorganisms as Streptococcus 
pyogenes alone and in combination with other strains, e.g., Serretia 
marcescens. These combinations have been found to be more effective. 
Donnelly, et aI, (79) studied the effects of these mixed bacterial 
toxins (Serratia marcescens and Streptococcus pyogenes) given i.p. to 
Swiss mice bearing the tumor subcutaneously. The toxins acting on 
Sarcoma 37 produced edema of cells pyknosis of nuclei, shrinkage of 
cells, cellular disintegration, hemorrhage, and eventual sloughing 
of the tumor, followed by healing and scar formation in those surviv-
It was found by other authors (Havas, et aI, 77) that these same 
bacterial toxins are less toxic when administered to normal mice than 
when given to mice bearing Sarcoma 37, and that surgical removal of 
six day old tumors from these mice returned them from a low to a 
relatively normal level of resistance to these bacterial toxins. 
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Havas and co-workers believed that the increased susceptibility of 
tumor-bearing animals to the toxins resulted from toxic products 
originating from the treated tumors undergoing necrosis. 
Tissue studies on mice given subcutaneous implants of incubated 
mixtures of Sarcoma 37 and Streptococcus pyogenes indicate that within 
24 hours the tumor cells are surrounded by a more intense inflammatory 
reaction than occurs in ordinary tumor implants (Havas, et aI, 80). 
The majority of sarcoma cells are necrotizing, but many are still 
viable. The inflammatory reaction increases up to one week, and there 
is abscess formation and necrosis. The lesions are composed of tumor 
cells (greatly reduced in pumber), cellular debris, and inflammatory 
exudate. By the third week, there is fibrosis and slow resolution of 
necrotic and inflammatory lesions. The mechanism of action by which 
the toxins produce tumor necrosis has not been decided. The evidence 
for a systemic effect on host-tumor relationships is strong. If there 
exists any host resistance to tumor development and growth, it may be 
mediated through a non-specific natural resistance or an antigen-
antibody phenomenom, or both. In any case, the bacterial products 
that have been used for their tumor-necrotizing qualities could stim-
ulate both of these defense mechanisms (80). 
c. Effects of Viruses on Sarcoma 37 
Wagner (81) treated Sarcoma 37 solid tumor fragments with (a) 
allantoic fluid (control), (b) WS influenza virus (non-neurotrophic), 
and (c) NWS virus (influenza A virus - encephalogenic varient), and 
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then transplanted them into mice subcutaneously. The WS strain showed 
no po1iferation potential in this tumor and others and failed to in-
fluence their growth. The NWS virus in the transplants gradually 
increased in titer to the fourth day, stayed constant through day 
seven. At this time, the tumor weight was greatly decreased (aver-
age weight - 0.112 grams) compared to that in the control (average 
weight - 0.598 grams). By day ten, titer was no longer demonstrable. 
Between the seventh and fourteenth days, the transplants grew at an 
accelerated rate and circulating antibody appeared. However, the 
virus was lost on the tenth passage. 
D. Effects of Polysaccharide Material on Sarcoma 37 
Polysaccharide material from yeasts, yeast-like fungi, many 
bacterial microorganisms (E. coli, Candida gui11ermondi, etc.), and 
polysaccharides from higher plants and synthetic polysaccharides 
have been tried with varying degrees of success upon solid tumors, 
ascites tumors, and cells in tissue culture. Sarcoma 37 has been 
used in a great many of these experiments. One thing is certain, 
with the same polysaccharide material, the results are often quite 
different depending upon the kind of tumor studied; solid tumor, 
ascites, or tumor cells in tissue culture. The mechanism of tumor 
damage has been considered by some as direct and by others as in-
direct. Many believe, however, that the cells are directly affected 
as shown by their rapid swelling and edema and nuclear damage. 
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Creech and Hankwitz, Jr. (82) injected polysaccharide lipid com-
plexes of S. marcescens and E. coli i.p. into eight week old Swiss 
mice with well established subcutaneous Sarcoma 37 (solid). They 
succeeded in producing major destruction of Sarcoma 37 and a high 
percentage of complete regression, but only after using such high 
levels of polysaccharide that 30 percent of their mice died from 
the effects. However, 50 percent of the mice remaining showed com-
plete regression. They found that multiple injections were only 
rarely more effective than a single injection of polysaccharide. 
Diller, et aI, (83), working with S. marcescens, found nuclear dam-
age in solid Sarcoma 37 visible microscopically 1~-2 hours after 
i.p. injection. 
Living and killed Candida species caused sloughing of Sarcoma 
37 tumors (solid) in varying degrees (Maknowski, et aI, 84). Candida 
guillermondi was found to be best with 80 percent sloughing when in-
jected i.v.. Following i.v. injection there was widespread distri-
bution of the organisms in normal tissues as well as in tumors, but 
there as no evidence of destruction of cells other than in the tumor. 
Also, no toxic symptoms developed in mice injected with the non-
pathogenic species in doses which caused necrosis in the tumor. 
Experiments were done using polysaccharides from higher plants 
as bryony root, burdock root, yucca leaf pulp, red clover, and others 
(Belkin, et aI, 85). Twenty-two of 28 of these polysaccharides in-
duced hemorrhagic necrosis in solid Sarcoma 37, transplanted intra-
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muscularly in CAF albino mice. Seventeen of these polysaccharides, when 
injected i.p. into mice carrying Sarcoma 37 ascites tumor, produced a 
progressive increase in cell volume (up to 90 times that of controls) 
and cytoplasmic vacuolization (which became most pronounced at 72-96 
hours). Another feature in Belkin's experiments was intraperitoneal 
leukocytosis, consisting mostly of granulocytes in different amounts 
depending on the polysaccharide used. By five or six days, normal 
cells began to appear again. Interestingly enough, some of the poly-
saccharides which produced hemorrhagic necrosis in solid tumors com-
pletely failed to produce swelling and vacuolization in ascites forms. 
Tissue cultures of Sarcoma 37 with a number of these polysaccharides 
yielded no results whatsoever. 
O'Malley, et aI, (86) reported that growth of Sarcoma 37 can be 
interrupted repeatedly by successive injections of S. marcescens 
polysaccharide. The tolerance induced by the first dose may be over-
come by increasing subsequent doses to higher levels. The death rate 
however is high. 
Most interesting results were obtained with the yeast polysac-
charides, zymosan, and especially hydroglucan, on solid mouse Sarcoma 
37 (Diller, et aI, 83). Intravenous injection of hydroglucan was most 
significant. Regression of 90-95 percent of solid Sarcoma 37 was ac-
complished with no lethality. Administration of the same amount of 
hydroglucan i.p., intramuscularly, and subcutaneously produced lower 
percentages of regression. As in Belkin's experiments (85), the 
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ascites form of the tumors were not affected. Some differences were 
noted between bacterial polysaccharides and yeast polysaccharides. 
With zymosan and hydroglucan at tumor necrotizing levels, there was 
tumor necrosis and resorption without hemorrhage, and there were no 
animal deaths. In contrast, bacterial polysaccharides produced 
vascular damage, hemorrhage, and numerous deaths. It is felt by 
Diller's group (83) that the mechanism of action of yeast polysac-
charides may not be the same as that of bacterial polysaccharides. 
The most notable feature of tumor regression with hydroglucan is the 
increased production of phagocytic cells not observed in some mice 
whose tumors are not regressing. Apparently, there is a host-
mediated reaction here which involves stimulation of the phagocytic 
elements of liver and spleen, and it is a matter of host response 
or failure to respond to yeast polysaccharides which determines 
tumor regression. Weiss, et aI, (83) discussed evidence for the as-
sumption that the ability of malignant growths to progress in the 
host reveals failure of antibody formation of phagocytic properties 
of the RE system. 
E. Drugs and Chemicals on Sarcgma 37 
Different chemical classes of drugs will damage tumor cells, and 
~here is no one group outstandingly effective. For instance, amino-
teropterin in doses of 0.5 or I mg/kg and thio~TEPA in doses of 1-2 
mg/kg i.p. showed their toxic activity by consistently decreasing 
free tumor cell concentration and the amount of exudation in ascites 
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Sarcoma 37 (87). Way, et aI, (88) showed that 8-azaguanine inhibited 
Sarcoma 37 in CAF mice in large doses. 
Table III lists experimental results with different chemicals 
(Shear, et aI, 89,90; Beck, et aI, 91). 
F. Hormones on Sarcoma 37 
Hormones may act beneficially or detrimentally on Sarcoma 37. 
1. Sex Hormones: Studies were done on the growth of ascites 
tumor cells in male mice previously treated with sex hormones (Goldie, 
et aI, 92). It was determined that extended preparation with high 
doses of androgens alone or androgens alternated with estrogens in-
duced in male mice a hormone imbalance which conditioned, for a 
limited time, the peritoneal cavity for increased spread and growth 
of ascites tumors. The concentration of free tumor cells was found 
to be less in estrogen-treated animals and in controls. 
2. Adrenal Cortical Hormones: In the work of Diller and others 
(93) in Sarcoma 37 transplanted subcutaneously in Carworth Farm mice, 
it was demonstrated that i.p. injection of adrenal cortical extract 
was capable of producing degenerative changes in the tumor and slough-
ing, especially in the female. There was a decrease in the size of 
the tumor following injection of adrenal cortical extract in males 
and females, but this inhibition of growth could not be maintained 
in the males, even with repeated doses of the extract. However, there 
was some spontaneous regression and sloughing showing that Sarcoma 37 
was somewhat precariously established in this strain. Further work of 
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Diller and associates (94) showed the following interesting results: 
1. In Sarcoma 37 tumor bearing mice (subcutaneously), 
adrenal cortical egtract injected i.p. produced de-
generative changes in the adrenal gland, especially 
in the medulla as well as in the subcutaneous tumor. 
There appeared to be greater damage in the adrenals 
of females injected with cortical extract than in 
males. 
2. Intra-peritoneal injection of S. marcescens polysac-
charide into mice, bearing Sarcoma 37 subcutaneously, 
produced degenerative changes in the tumor within six 
hours and rapid sloughing in one of every four mice. 
However, an equal number died from the treatment. At 
the same time, this polysaccharide produced hemorrhage 
and degenerative changes in the adrenal, again especially 
in the medulla. 
3. Simultaneous administration of the polysaccharide and 
adrenal cortical extract decreased the toxic effect, 
i.e.) more animals survived. There was also a minimal 
effect in the adrenal and a delayed or slower tumor 
breakdown, 24 hours instead of six hours. The adrenal 
medulla and cortex both appeared relatively normal by 
24 hours. 
4. Interestingly enough, in non~tumor animals, or in 
animals with tumors that do not respond to these agents 
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through tumor degeneration, the adrenal damage follow-
ing the administration of the polysaccharide alone, the 
adrenal cortical extract alone, or both together appeared 
to pe negligible. 
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TABLE II 
SURVIVAL TIMES OF MICE AND ROUTES OF INJECTION (SARCOMA 37) 
Modified after Goldie, et aI, 68 
SURVIVAL TIMES IN DAYS 
Intra-
pleural Flank Foreleg Hindleg I.P. 




WITH POTENCY IN PRODUCING DAMAGE 
IN SARCOMA 37 
Modified from Shear, et aI, 89, 90 
and Beck, et aI, 91 
No. Comp. Exam. 









Di & Tri Phenyl methanes 
Amidines and quanidines 
Arsenicals (90) 
Aromatic tri-valent Arsenicals 
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VII. Related Experiments 
Several experiments have shown that transformation of Cortisol to 
its products is different in normal cells than in different types of 
abnormal cells. 
A. Normal Connective Tissue 
That the fibroblast is the main site of cortisol (F) metabolism 
is supported by the following experiments from our laboratory (29,64, 
95). Cortisol Cl4 was incubated with normal AK mouse loose connective 
tissue. Several compounds were isolated and identified, including 
mainly cortisone (E), 20 epi substance "E" of Reichstein, a slight 
amount of dihydrocortisol, Reichstein's "U", corticosterone, and IIBOH 
androstenedione. The results indicated that normal fibroblasts prefer-
entially oxidize position C-II of the cortisol molecule to form corti-
sone. The main changes were seen to be oxidation and reduction of the 
substituted groups on the gonane nucleus. Since the fibroblast makes 
up 90 percent of connective tissue, one may conclude that it must be 
this cell that performs these conversions. 
B. Tissue Culture Cells 
Many experiments showed (28,35,39,95,96), first, that uterine fibro-
blasts in tissue culture have a greater ability to reduce the C-20 
position than do normal fibroblasts. Also, androstenedione was formed 
in greater amount than in normal connective tissue and cortisone was 
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not the main product of conversion as in normal connective tissue. It 
was found that these fibroblasts, when incubated with cortisol C14 , 
formed cortisone, Reichstein's "E" and "U", corticosterone, and llBOH 
androstenedione; however, Reichstein's "E" was mostly in the B form. 
Second, a resistance strain of uterine fibroblasts was found to 
metabolize twice as much cortisol per unit time as did a sensitive 
strain (97,98). When cortisol C14 was incubated with two strains of 
uterine fibroblasts, one of which was resistant to the growth inhibi-
tion of cortisol (U12-35) and the other sensitive to cortisol growth 
inhibition (U12-79), it was found that both strains metabolized corti-
sol to steroid products which did ~ot differ significantly in either 
types or relative quantities, but that the resistant strain metab-
olized more cortisol per unit of time. 
Third, it has been shown (99) that cortisol is the active form of 
the steroid molecule, whereas other products are less active. The 
metabolites produced from cortisol C14 incubation with uterine fibro-
blasts were shown to be less inhibitory to growth than cortisol itself. 
Therefore, the more cortisol converted to inactive products, the less 
active cortisol there was to cause destruction of fibroblasts or inhibit 
their growth. 
c. Fibrosarcoma Cells 
Products not occurring in normal fibroblast conversion may occur in 
fibrosarcoma cell conversion. In experiments with mice (Berliner, 100), 
cortisol was found to be converted by malignant cells to cortisone, sub-
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stances "E" and "U" of Reichstein, corticosterone, dihydro F, and llBOH 
androstenedione. Some 11 keto-etiocholanedione, which is not seen in 
normal connective tissue, was formed also. Fibrosarcoma cells metab-
olized cortisol to a greater extent than did normal fibroblasts. 
D. Osteosarcoma Cells 
Osteosarcoma cells of dogs were found to catabolize cortisol C14 
and the metabolites formed were found to be the same as those produced 
by normal fibroblasts, but they were produced in greater amounts (39, 
101). Quantitative differences were seen in metabolic products of in-
cubated fresh osteosarcoma cells and those grown in tissue culture. 
Tissue culture osteosarcoma cells reduced cortisol at position 20 in a 
greater amount than fresh cells, but oxid~zed C-ll to a lesser degree. 
Also, the tissue culture osteosarcoma cells incubated with cortisone 
C14 were not able to reduce the molecule to cortisol, whereas the 
freshly isolated osteosarcoma cells could (102). 
E. Malignant Lymphocytes 
The malignant lymphocytes have been relatively extensively in-
vestigated (39,58,62,103,104,105,106). In mice, malignant lymphocytes 
transformed the active cortisol molecule to metabolic products which 
were incapable of producing lymphocyte destruction or regulating lympho-
cytopoiesis. When malignant lymphocytes were incubated with cortisol 
C14, cortisol converted to cortisone, substances "E" and "U" of Reich-
stein, and llBOH androstenedione. They had the ability to reduce the 
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C~20 keto~group and oxidize the side chain to form C-19 compounds in 
very large amounts. Normal lymphocytes performed the same conversions, 
but in small amounts. In mice, immature lymphocytes and lymphocytes 
after repeated large doses of cortisol were also found to have an in-
creased capacity to metabolize cortisol over lyntphocytes from normal 
mice, but they did not do so to the same extent as did malignant lympho-
cytes. 
F. Studies in Man 
When cortisol metabolism was compared in a normal subject and in a 
patient with acute lymphatic leukemia, it was observed that llBOH etio~ 
cholanolone (from llBOH androstenedione) was greatly increased in the 
urine of the leukemic patient over that of the normal person (100,107~ 
108). Years ago, Dobriner (109) studied patients with lymphatic leu-
kemia and other cancers and had found this substance to be present in 
their urine. At that time, however, his methods did not pick it up in 
normal urine. 
Slaunwhite, et aI, (110) studied patients with prostatic cancer, 
and noted that they excreted large amounts of 11-oxygenated-17-keto-
steroids upon receiving cortisone. ~ormal individuals receiving the 
same quantity of cortisone exc~eted only small amounts. He showed 
similar results in a lung cancer patient. 
Sokal and Buchwald (111) gave cortisol acetate to patients with 
advanced carcinoma of the prostate and noted that they excreted greater 
amounts of l7-ketosteroids than did normal persons treated similarly. 
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In other carcinomatous conditions, 17-ketosteroids were found in large 
amounts in the urine, while they were rare in normal persons. 
Other investigators (112) reported that patients with estrogen 
resistant tumors catabolized ~stradiol 4c14 to a greater extent than 
did patients with estrogen sensitive tumors. 
THE EXPERIMENT 
The pre~ent experiment investigates the interconversion of labeled 
cortisol and cortisone in both normal connective tissue of mice and in 
Sarcoma 37 of hamsters. 
Many experiments have been done with normal connective tissue cells 
and abnormal cells using cortisol (F4C14) or using cortisone (E4C14), 
noting the ability of the cells to metabolize either of these steroids. 
The present experiment labels not only the cortisol (F) molecule and 
follows its products of conversion, but at the same time labels corti-
sone (E) and follows its metabolic pattern. Equimolecular quantities 
of cortisol-7-H3 (F-7-H3) and cortisone-4-C14 (E4C14) were added to the 
incubation mixtures of fibroblasts of mice and Sarcoma 37 cells of ham-
sters, providing information on the conversion of cortisol to cortisone, 
cortisone to cortisol, and conversion products from cortisol, conversion 
products from cortisone, etc. 
I. Materials and Methods 
A. Subjects and Tissues 
1. Normal Connective Tissue: One hundred twenty-eight male and 
female AK mice bred in our laboratory were weaned at 8-10 weeks of age. 
They were mixed and divided into two groups of 64 animals each. One 
group was sacrificed one day, the second group the next. Each group 
was sacrificed by neck fracture, then a dorsal air pocket was quickly 
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made and the underlying connective tissue was removed. The connective 
tissue from eight animals was used for each incubation, together with 
equal amounts of a hormone mixture containing ~m of cortisone-4-C14 
(E4C14) and l~m of cortisol-7-H3 (F-7-H3), and 10 cc of phosphate 
buffer at pH 7.4. 
2. Sarcoma 37: Ten golden hamsters with Sarcoma 37, from a 
colony with Sarcoma 37 from the University of Rochester Medical Center, 
Rochester, New York, were used in this part of the experiment. The 
hamsters, five males and five females, were inoculated with Sarcoma 37 
in the subcutaneous dorsal area when they were 44 days old. They were 
received the next day. The hamsters had been fed on Purina Lab Chow 
with lettuce every 5-6 days. In our laboratory, they were fed a mix-
ture of Purina Lab Chow pellets and Friskies Dog Cubes, and a mixture 
of wheat, liver oil, and meal; also lettuce every few days. Within a 
week, a slight growth of the tumors could be detected. By two weeks, 
the tumor was at least 3 cm. in diameter. Fifteen days after tumor im-
plant, six hamsters were sacrificed by decapitation. Two tumors were 
placed in 10 percent formalin to be studied histologically. See figure 
3. The tUmors were put together, weighed, minced, and incubated. Each 
incubation contained 300 mg. of tumor tissue with equal amounts of a 
hormone mixture of lrm of cortisone-4-C14 and ~m of cortisol~7-H3 and 
10 cc of phosphate buffer at pH 7.4. 
B. Methods of Extraction 
The incubations were stopped at various time intervals; 1, 5, 15, 
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30 minutes, and 1, 2, 3, 4 hours in the case of normal tissue; and only 
through 3 hours with Sarcoma 37, since it was found that by four hours, 
most of the cells had died or been destroyed. Zero and 3 or 4 hour con-
trols of the hormone mixture, plus buffer, without tissue were also 
carried through to detect changes during the incubation procedure. The 
incubations were done at 370 C temperature with constant movement, and 
a duplicate of each incubation flask was always made. When the incu-
bation was completed, acetone was added to stop the metabolic processes. 
The contents of each flask were homogenated and extracted three 
times with hot acetone, passed through a filter paper, and evaporated 
in a vacuum. The aqueous residue was re~extracted with chloroform 
three times and evaporated to dryness. This dried residue was trans-
ferred into a centrifuge tube, using a 1:1 mixture of chloroform-
methanol. The mixture was dried under nitrogen. To each extract 100 
each of non-radioactive cortisol and cortisone were added as carriers 
in order to detect the positions of the hormones on paper under ultra-
violet light. One dimensional descending paper chromatography was done, 
using the Zaffaroni methods. Strips 2.5 cm. were used in normal con-
nective tissue, and strips 3.0 cm. in sarcoma tissue. The solvents 
used were hexane, overnight, to eliminate the fat, and chloroform, to 
drop from the strip for one hour. Isolations and identifications were 
made following the techniques described by Berliner (113,114). Equal 
paper areas corresponding to the sites of absorption of cortisol and 
cortisone were cut out and eluted with methanol directly into scintil-
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lator vials and dried under nitrogen. Other areas corresponding to 
Reichstein's "E" and "U", C-19 metabolites, and the droppings were 
eluted with methanol into scintillator vials and dried under nitro-
gen also. Twenty mI. of scintillator fluid was freshly prepared (I) 
and added to each vial, which was then counted in a scintillator. 
Since each vial may contain both tritium and carbon 14, the follow-
ing procedure was used to evaluate the radioactivity in each vial. 
(I) Scintillator fluid - P.P.O. - 4 gms/liter + POPOP - 100 gms/liter 
of toluene 
C. Analysis of Data 
The counting of the samples containing carbon 14 and tritium was 
done in a Packard Tri-Carb Liquid Scintillation Spectrometer, Series 
3l4A. The following settings were used: High voltage tap 6.00 
(1150 volts), analysis mode 2 split. Disciminator settings are 
AAl=lO volts, B=50 volts, and C=70 volts. With these settings, H3 
is counted in channel I (10-50 volts) and C14 in channel II (70-
volts). If it were not for the fact that some tritium counts spill 
over into channel II, the calculation would be much simpler. 
Since we have carbon 14 in channel I and tritium in channel II, 
we must go to simultaneous equations for calculating the amount of 
carbon 14 and tritium in each channel. In order to do this, a stand-
ard of pure C14 and a standard of pure H3 are required -
Let A count rate Tritium Standard 
Leb B = count rate Carbon14 Standard 
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Let K = count rate of the sample 
X = the fraction of standard A in the specimen 
y = the fraction of standard B in the specimen 
In the specimen, the sum of the individual count rates = total count 
rate. 
Kl in channel I I 
;I 
K2 in channel II 
Therefore: 
x = KlB2 - K2Bl 
AlB2 
- A2Bl (1) 
KlA2 - K2Al 
Y ;:;: 
BlA2 - B2Al (2) 
This form of the equation lends itself very readily to solution 
by high speed digital computers. 
For those who do not have access to a computer, the following 
forms are more adaptable for solution, using a desk calculator. 
Bl 
K2 Kl 
- B2 X 
Bl 
A2 Al - B2 (3) 






In the experiments described below, a Burroughs 205 Datatron 
Computer was programmed in such manner that all calculations involved 
in solving the above equations (1 and 2) were made in one operation. 
x = the percentage of the H3 standard in the sample based on 
radioactivity, and Y = the percentage of the C14 standard in the 
same sample based on radioactivity. The computed results may be 
seen in Tables IV, V, VI, and VII for the time intervals studied. 
Compounds analyzed include cortisol (F), cortisone (E), and 
Reichstein's "E" and "U", and C-19 metabolites, 
The results were then plotted on bar graphs in percent. See 
figures 5 - 10. 
II. Results 
Histological examination of tissue slices and pictures con-
firmed that the tumor was a sarcoma. See figure 3. 
The results of the experiment are summarized in figure 4 and 
figures 5 - 10. The results of the experiment are summarized in 
Tables IV through VII. 
A9 Conversion of Cortisol (F) 
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1. Conversion of Cortisol (FH3) to Cortisone (EH3): In normal 
connective tissue, cortisol is converted to cortisone. The amount of 
conversion increases with time to about 20 percent at two and three 
hours. In sarcoma tissue, cortisol is also converted to cortisone, but 
59 
in very small amounts. The conversion reaches its height at two hours 
when it is approximately three percent. It drops off at three hours 
to about one percent. These data are represented in figure 5. 
2. Conversion of Cortisol (FH3) to Other Products: In normal 
connective tissue, cortisol is converted to other products also; Reich-
stein's "U", Reichstein's "E", and C-19 metabolites. Conversion to 
these products considered together depends on time. At 15 minutes, it 
reaches its peak at about six percent and decreases at 30 minutes to 
four and one-half percent. It remains at about five percent during 
the remainder of the experiment. All in all, conversion does not 
change greatly. Sarcoma 37 conversion of cortisol to all products 
but cortisone increases suddenly at five minutes to 12 percent, from 
about three percent at one minute. This drops at 15 minutes to about 
three percent and increases slowly to about six percent at two hours. 
However, there is a large increase by three hours to 21 percent. These 
data are represented in figure 6. 
3. Conversion of Cortisol (FH3) to C-19 Metabolites Alone: In 
normal connective tissue, the conversion of cortisol to C-19 metabolites 
plus droppings is small. It ranges from l~ to nearly three percent, 
averaging two percent at three hours. Conversion of cortisol to C-19 
metabolites in sarcoma is also small. The greatest increase in con-
version above that of normal tissue is at five minutes, when it increases 
to about nine percent. It then drops to about l~ percent at 15 minutes, 
slowly rises, and levels off between three and four percent at two and 
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three hours. These data are represented in figure 7. 
B. Conversion of Cortisone (E) 
1. Conversion of Cortisone (EC14) to Cortisol (FC14): In normal 
connective tissue) conversion of cortisone to cortisol increases with 
time up to 40 percent at three hours; the greatest increase, from 10 
percent to 40 percent, occurring during the last hour. In sarcoma, the 
amount of conversion of cortison.e to cortisol is very small, reaching 
only a little over four percent at three hours. This conversion appears 
to be the one of importance in distinguishing sarcoma cells from normal 
cells. These data are represented in figure 8. 
2. Conversion of Cortisone (EC14) to Other Products: In normal 
connective tissue, there is conversion of cortisone to other products, 
i.e., Reichstein's "E" and "U", and C-19 metabolites. Considered to-
gether, these products are formed in greater amount than the identical 
products from cortisol. (Compare figures 6 and 9.) In normal tissue, 
Reichstein's lIU H and nE", and C-19 metabolites are already formed at 
one minute, and in general, they slowly increase to about 12 percent 
by three hours. In sarcoma, the picture is radically different. At 
one minute, the conversion products are similar in amount to the normal 
tissue, but by five minutes, the products in sarcoma suddenly increase 
to 40 percent, compared to nine percent in normal tissue. Then the 
products drop to about 25 percent at 15 minutes and remain relatively 
level for the rest of the three hour incubation. These data are repre-
sented in figure 9. 
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3. Conversion of Cortisone (EC14) to C .. 19 Metabolites Alone: In 
normal connective tissue, C .. 19 metabolites, plus droppings, are not 
formed in large amounts. They average about six percent from one minute 
to three hours. However, the amount of C-19 metabolites formed is greater 
than that formed from cortisol, which averages less than three percent. 
(Compare figures 7 and 10.) In sarcoma, the picture is again very dif-
ferent. At one minute, the amount of C-19 metabolites formed is about 
one percent. By five minutes it increases to 38 percent. At 15 minutes 
it decreases to about 24 percent and stays there through one hour. This 
decreases at two hours to about 10 percent, but increases again to 20 
percent at three hours. These data are represented in figure 10. 
III. Discussion 
This experiment confirms that fibroblasts in loose connective 
tissue are capable of converting cortisol to cortisone and cortisone 
back to cortisol, and that loose connective tissue fibroblasts are 
capable of reducing the C-20 keto position to H .. C-OH and oxidizing 
the side chain to form C-19 metabolites. In normal fibroblasts, con-
version to C-19 metabolites occurs in small amounts, while in sarcoma 
cells it occurs in large amounts. Also, there is greater inactivation 
of the active molecule cortisol in sarcoma cells. Further, the ex-
periment shows: (1) That conversion products from cortisone are formed 
in greater amounts than those from cortisol in both normal and sarcoma 
cells; (2) these conversion products occur in much greater amounts in 
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sarcoma cells than in normal cells; and (3) in normal connective tissue, 
conversion products are formed almost immediately, whereas in sarcoma 
cells, the formation of conversion products always lags in conversions 
from cortisol to cortisone and cortisone to cortisol. 
First, consider the conversion from cortisol to cortisone. In 
normal mouse fibroblasts, the rate of conversion of cortisol to corti-
sone (C-ll oxidation) is detectable in the first five minutes of incu-
bation and is fairly large in amount. However, in sarcoma the rate of 
conversion is not detectable until two hours of incubation, and even 
at this time the amount formed is very small (figure 5). 
The conversion of cortisone to cortisol (C-ll reduction) is rep-
resented in figure 8. Conversion is first seen in normal cells by 15 
minutes, whereas conversion by sarcoma cells does not appear until one 
hour. The rate of reduction by sarcoma cells is again extremely small 
as compared with that of normal cells. This C-ll reduction appears to 
be the important conversion ~ sarcoma cells since it shows that very 
little cortisone is converted to the active form cortisol. Therefore, 
little cortisol is available to the sarcoma cells. It is obvious that 
the rate of conversion of cortisol to cortisone and cortisone to corti-
sol, or the ratio of interconversion in sarcoma cells is much different 
from that in normal cells. 
Conversion of cortisol H3 to other products, except cortisone, in 
normal tissue appears at one minute and increases slightly over a three 
hour period. (See figure 6.) In sarcoma tissue, conversion products 
63 
also appear by one minute, but rise suddenly above those of normal 
tissue at five minutes, and decrease to almost the level of normal 
tissue until two hours. Between two and three hours, there is a large 
increase to four times that found in normal tissue. 
In normal tissue, conversion of cortisone Cl4 to other products, 
except cortisol, appears at one minute and rises slowly. (see figure 
9.) Conversion products from cortisone are formed in a greater amount 
than those from cortisol. The amount of conversion products from 
cortisone Cl4 in sarcoma cells is greatly different. Even at one 
minute conversion products are formed in greater amount than in normal 
cells. By five minutes the amount of conversion products rises to over 
four times that found in normal cells. Conversion products continue to 
be formed in great amount, leveling off at three hours to about twice 
that of normal cells. Over the three hour period, conversion products 
from cortisone Cl4 in sarcoma cells are again formed in greater amount 
than from cortisol H3 in sarcoma cells over the same period. (See 
figures 6 and 9.) 
The picture is similar when we consider the formation of C-19 
metabolites from cortisol H3 and cortisone C14. In normal tissue, the 
conversion of cortisol H3 to C-19 metabolites is small, appearing at 
one minute and remaining about the same over the three hour period. In 
conversion from cortisone C14, the formation of C-19 metabolites is 
somewhat increased, but not greatly. It appears at one minute and 
varies only slightly over the three hour period. 
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In sarcoma tissue, conversion from cortisol H3 appears at one min-
ute and is very small and below that of normal tissue. It rises at 
five minutes to over three times that of normal tissue, drops down at 
15 minutes and again rises above normal connective tissue at 30 minutes, 
and continues so to three hours. 
Conversion from cortisone C14 in sarcoma tissue appears at one 
minute in small amount and below that of normal tissue, rises at five 
minutes to far above that of normal tissue. It drops at 15 minutes 
but still remains far above normal tissue, and continues in much greater 
amount than that found in normal tissue to three hours. Again the total 
conversion over the three hour period from cortisone C14 to C-19 metab-
olites is much greater than the total conversion from cortisol H3 to 
C-19 metabolites. 
Enzyme systems are essential to the transformations of cortisol 
by fibroblasts and other cells. These include llBOH dehydrogenase 
systems and the presence of co-factors as DPN, TPN, DPNH, and TPNH (30). 
Therefore, the availability of a particular co-factor and whether it is 
oxidized or reduced form will determine the amount of metabolism to active 
or inactive steroid hormones. Talalay and his workers (115) considered 
that the steroids act as hydrogen donors and acceptors, participating 
in the reversible oxidation and reduction of diphospho and triphospho 
pyridine nucleotide. 
Previous studies and the results of this experiment show that 
malignant cells do metabolize steroids to inactive metabolic products 
65 
to a greater extent than do their normal counterparts, and that the 
presence of tumor or leukemia favors the splitting of the side chain 
with the formation of C-19 compounds. 
This experiment shows that it is C-ll reduction that is partic-
ularly or especially impaired in sarcoma cells. 
Other experiments have labeled either cortisol or cortisone and 
traced the metabolic products from one or the other. The present ex-
periment labels both cortisol and cortisone in mouse and hamster tissue 
and shows not only the metabolic products from cortisol and from corti-
sone, but also the rate and amount of interconversion of these two 
hormones in both malignant and normal cells. Moreover, labeling of 
both cortisol and cortisone in normal and malignant cells clearly de-
picts that the major defect in sarcoma cell conversion is in C-ll 
reduction. 
This C-ll reduction appears to be the conversion of great impor-
tance in distinguishing the metabolism of sarcoma cells from that of 
normal cells. These sarcoma cells have somehow lost the capacity to 
convert a large amount of the potentially active form cortisone to the 
active form cortisol, and therefore the amount of cortisol available is 
far less than that required to produce the same effect as in normal cells. 
Thus, control over cell growth and other processes may be lost. 
Knowing about rates and amounts of interconversion in normal and 
malignant tissues is basic for devising methods of interfering with ab-
normal metabolism in malignant cells. 
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It has been found that substitution of a methyl group on the second 
carbon of cortisol and of cortisone prevents their interconversion in 
vitro and in vivo by such cells as fibroblasts and lymphocytes (111). 
Thus, 2-methyl cortisol is even more anti-inflammatory than cortisol 
itself, and it could very likely be more effective than cortisol on 
malignant cells. In fact, other substitutions on the steroid nucleus, 
as in fluocinolone acetonide, may be even more effective on malignant 
cells than naturally occurring hormones. 
Possible explanations for the difference between normal and sar-
coma cells observed here might be as follows: (1) Enzymatic defects 
or co-factor imbalance or both could affect biotransformation and thus 
the ability of cells to inactivate hormones; (2) changes in cell mem-
brane permeability might selectively inhibit or increase contact of 
steroids with the necessary enzyme-co~enzyme system (39); (3) changes 
in nucleic acids may occur, thereby altering the genes themselves; 
(4) inhibitory factors may no longer enter the cells (116); (5) hor-
mone binding with proteins or other substances may make the steroids 
unavailable at the cell surface (117,118); and (6) minimal C-ll re-
duction in sarcoma cells, as shown in this experiment, may enable these 
tumor cells to inactivate cortisol faster than in normal cells, enable 
them to convert more easily that which is present in inactive forms, 
influence their resistance to increased amounts of hormone, and in-
fluence the requirement of greater quantities of cortisol than normal 
cells to produce the same effect. On the other hand, normal cells 
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through active C-ll reduction can mainta~n more molecules in the act-
ive state and so keep sufficient cortisol available to protect the 
animal against stressors and maintain the homeostasis so necessary to 
the normal functioning of the organism. 
Several things appear to me to be very clear: 
1. Since conversions of cortisol to cortisone in sarcoma tissue 
are delayed (they do not appear for two hours) and are very small in 
amount (one to three percent); and 
2. Since conversions of cortisol to cortisone in normal connect-
ive tissue appear very rapidly (within five minutes) and are large in 
amount (20 percent); and 
3. Since conversions of cortisone to cortisol in sarcoma tissue 
are again delayed (they do not appear for one hour) and are again very 
small in amount (four percent); and 
4. Since conversions of cortisone to cortisol in normal connect-
ive tissue appear quite rapidly (15 minutes) and are large in amount 
(40 percent); and 
5. Since conversion products from both cortisol and cortisone 
appear immediately (within one minute) in both normal and sarcoma 
tissue; and 
6. Since the llBOH dehydrogenase systems and the co-enzyme 
DPN-DPNH or TPN-TPNH are considered necessary for the conversions of 
cortisol to cortisone and cortisone to cortisol, then 
It seems obvious that the co-enzymes may have been destroyed, 
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greatly incapacitated or inactivated, missing, altered, or in some way 
prevented from contact with the steroids cortisol and cortisone. Con-
sequently, the normal pathway of cortisol to cortisone or cortisone to 
cortisol in sarcoma cells seems to have been circumvented, and a new 
or altered pathway may have permitted inactive metabolic products to 
be formed rapidly and in large amounts. 
Therefore, it is suggested that sarcoma experiments in which 
DPNH+ or TPNH+ is injected with the tumor cells and after the tumor 
has begun to grow might prove most interesting and possibly enlight-
ening. Co-enzymes DPNH+ or TPNH+ are suggested because in C-II 
reduction more of the active steroid may be made available to pre-
vent or decrease the rapid metabolic inactivation of this steroid 
which may lead to or may be a consequence of cell malignancy. 
Further, work should be continued on the nature and amounts of 
the C-19 metabolites formed in both the normal and especially in sar-
coma cells 
Finally, the success of Diller's work with hydroglucan on the 
sloughing of 90~95 percent of solid S-37 tumors in mice without lethal-
ity suggests that experiments should be done using hydroglucan or pos-
sibly glucan alone and using one or the other together with DPNH+ or 
TPNH+. Also study of gluean, with the aim of determining its mechanism 
of action, would prove most interesting as would further investigations 
on the possible aptigen-antibody relationships which may be involved 
in tumor production and destruction as discussed here. 
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lV. Summary 
The present experiment was designed to investigate a part of the 
connective tissue steroid metabolism, which is so important to the 
normal physiological state of an organism. 
Several conclusions can be drawn from this experiment: 
1. The rate of interconversion from cortisol to cortisone and 
from cortisone to cortisol is very different in sarcoma cells than in 
normal cells. 
2. In conversions of cortisol to cortisone and cortisone to cor-
tisol, the rate of biotransformation begins more slowly in the malignant 
cells. Perhaps for some reason cortisol and cortisone are unable to 
enter malignant cells as rapidly as normal cells, or the enzymes neces-
sary to the reaction have been incapacitated or inactivated. 
3. The conversion to inactive products is much greater in sarcoma 
cells than in normal cells, so that sarcoma cells seem to squander the 
biological material necessary to protect the organism against stressors. 
4. In the present experiment~ conversion to inactive products is 
greater from cortisone C14 than from cortisol H3, especially in sarcoma 
cells. 
5. In normal cells, C-ll oxidation is prominent (20 percent at 
three hours), and it is second only to C-ll reduction which is twice 
as great (40 percent at three hours). 
6. In sarcoma cells, C-ll oxidation is very small (1-3 percent 
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at three hours), so also is C-II reduction (4 percent at three hours). 
7. In normal cells~ C-li reduction is tremendous. This enables 
normal cells to keep sufficient cortisol molecules in the active state 
to protect the animal against stressors and maintain the homeostasis 
necessary to the normal functioning of the organism .. 
8. However~ sarcoma cells have lost the capacity to convert a 
large amount of the potentially active cortisone to cortisol (C-II re-
duction)~ Thus, the amount of cortisol available is less than in normal 
cells and control over growth and other processes may be lost. If this 
applies to the whole animal, peripheral fibroblastic-induced adrenal 
cortical insufficiency would be produced, leaving less cortisol present 
to protect the organism against inflammatory disease and noxious or 
chemical substances. In this way, the homeostasis so necessary to the 
normal state is disrupted. 
If we can discover at what point in normal fibroblast metabolism 
the capacity of C-Il reduction is lost, we may come closer to the 
final enigma of the cancer process and thereby have a better chance 
to control it. But to do this, it is necessary to understand the cell 
itself and its environ..TIlent and to understand the metabolism of normal 
and of malignant cells. By furthering these studies we will be better 
equipped to develop synthetic hormones and other means which may cause 
destruction of carcinomatous lesions without being toxic to the organism. 
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CD Histological Appearance of Sarcoma 37 
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Area I - R. "E" *0.0235 2 
.,b'<:0.01688 
Area II - FH3 *S t d. 
**Std. 
Area III - R "U" *0.00900 
~\:* 0 
Area IV - EC14 *Std. 
**Std. 
Area V - C-19 *0.08358 
Metabolites **0.02206 
Area VI - *0.01214 
Droppings **0.00174 
Areas V & VI - *0.09572 
Total **0.03800 
* - EC14 
** - FH3 
TABLE IV 
SUMMARY OF EXPERIMENTAL RESULTS 
NORMAL CONNECTIVE TISSUE 
4 hrs. 1 min. 5 min. 15 min. 
Control 
Average Average Average Average 
0.06630 0.01628 0.02335 0.01706 
0.02686 0.00804 0.01363 0.01486 
0 0 0 0.02682 
0.91947 1. 06160 1. 06293 0.97779 
0.00600 0.00600 0.00800 0.01216 
0 0.00500 0.00500 0.02533 
0 .88911 1.08898 1.03549 1.04976 
0 0 0.01520 0.04456 
0.04139 0.03862 0.03428 0.04122 
0.01194 0.00525 0.00917 0.01298 
0.04935 0.02660 0.02326 0.02382 
0.02227 0.01177 0.01305 0.01227 
0.09074 0.06522 0.05754 0.06504 
0.03421 0.01702 0.02222 0.02525 
Cortisone 
Cortisol 
30 min. 1 hr . 
Average Avera~ 
0 .01779 0. 02452 
0 .01434 0.01722 
0 .04435 0 .09234 
0 .96120 0.87 113 
0.01072 0 .02046 
0 .00909 0 . 00 915 
1.0571 7 1.05524 
0.06922 0 .18523 
0.03099 0 .01518 
0 .0076 1 0 .00764 







































SUMMARY OF EXPERIMENTAL RESULTS 
SARCOMA 37 
3 hrs. 1 min. 5 min. 15 min. 30 min. 1 hr. 2 hrs. 3 hrs. 
Control 
Average Average Average Average Average Average Average Average 
Area I - R. "E" * 0.00364 0.02350 0.01825 0.02358 0.01639 0.01704 0.00790 
** 0.00302 0.01950 0.00869 0.01239 0.01010 0.01844 0.00570 
Area II - FH3 *0.01178 0 0 0 0 0.01884 0.03789 0.04427 
j"*1.00497 0.98992 0.80904 0.98308 0.97048 0.96995 0.86424 0.71967 
Area III - R. "U" * 0.06340 0.00510 0.01172 0.00819 0.01972 0.14316 0.02740 
** 0.00786 0.00864 0.00737 0.00650 0.00372 0.00802 0.17080 
Area IV - EC14 *1. 07056 1. 12715 0.71152 0.93928 0.97820 0.93306 0.9l867 0.92667 
** 0 0 0 0 0 0 0.02948 0.01080 
Area V - C-19 * 0.02894 0.25518 0.16666 0.14124 0.15037 0.05440 0.01576 
Metabolites ** 0.00732 0.009l5 0.00638 0.01288 0.01298 0.02354 0.02488 
Area VI - * 0.01250 0.12220 0.07011 0.09005 0.08546 0.05296 0.04492 
Droppings ** 0.00339 0.08169 0.01078 0.01738 0.01516 0.01493 0.01144 
Total * 0.04144 0.37738 0.23677 0.23129 0.23583 0.10736 0.20252 
** 0.01071 0.09084 0.01716 0.03026 0.02814 0.03847 0.03632 
* - EC14 Cortisone 
** - FH3 Cortisol 
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TABLE VI 
SUMMARY OF EXPERIMENTAL RESULTS 
H3 PRODUCTS 
NORMAL TISSUE 
Time C-19 Met. AU 
Min. R. liE" R. "u" + Dr. Except E F to E 
1 min. 0 . 8 0.5 1.7 3.0 0 
5 min. 1.3 0.5 2.2 4.0 1.5 
15 min. 1.5 2.5 2.5 6.5 4.4 
30 min. 1.4 0.9 2.3 4.6 6.9 
1 hr. 1.7 0.9 2.8 5.4 18.5 
2 hrs. 1.3 1.0 2.5 4.8 21.6 
3 hrs. 1.9 1.4 1. 9 (2%) 5.2(5%) 19.7(20%) 
SARCOMA TI8S UE 
1 min. 0.3 0.78 1.0 2.0 0 
5 min. 1.9 0.86 9.1 U.8 0 
15 min. 0.87 0.73 1.72 3.34 0 
30 min. 1.2 0.65 3.0 4.85 0 
1 hr. 1.0 0.37 2.8 4.2 0 
2 hrs. 1.8 0.8 3.8 6.4 2.9 ) 
)- 1-3% 
3 hrs. 0.57 17.1 3.6(4%) 21. 27 (21%) 1.1 ) 
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TABLE VII 
SUMMARY OF EXPERIMENTAL RESULTS 
C 14 PRODUC TS 
NORMAL TISSUE 
C-19 Met. All 
Time R. "E" R. "U" + Dr. Except F E to F 
1 min. 1.6 0.5 6.5 8.6 0 
5 min. 2.3 0.8 5.7 8.8 0 
15 min. 1.7 1.2 6.5 9.4 2.6 
30 min. 1.8 1.1 5.9 8.8 4.4 
1 hr. 2.4 2.0 6.7 11.1 9.2 
2 hrs. 1.8 2.8 7.3 11.9 10.2 
3 hrs. 2.1 4.6 6.1(6%) 12.8{12- 40.0 (40%) 
13%) 
SARCOMA TISSUE 
1 min. 0.36 9.2 4.1 13.7 0 
5 min. 2.4 0.5 37.7 40.6 0 
15 min. 1.8 1.2 23.6 26.6 0 
30 min. 2.4 0.8 23.1 26.3 0 
1 hr. 1.6 1. 97 23.5 27.0 1.8 
2 hrs. 1.7 14.3 10.7 26.7 3.7 
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